Two-year overall survival rate in patients with steroid-resistant acute GvHD was 60% MELBOURNE, Au...
MELBOURNE, Australia, April 8, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynat...
MELBOURNE, Australia, March 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynat...
MELBOURNE, Australia, Feb. 26, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynat...
Key Highlights: * Cynata to collaborate with Leiden University Medical Center (LUMC) in the Neth...
Key Highlights: * US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CY...
Key highlights * Cynata and Fujifilm have entered into a new strategic partnership which include...